Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Entyvio (SC) (vedolizumab)
pCPA File Number:
21228
Negotiation Status:
Active Negotiation
Indication(s):
Ulcerative Colitis
Sponsor/Manufacturer:
Takeda Canada Inc.
CADTH Project Number:
SR0635-000
pCPA Engagement Letter Issued:
2020-10-19
Negotiation Process Concluded:
Not Applicable